Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 2/2016

01-02-2016 | Head and Neck Cancers (EY Hanna, Section Editor)

The Role of Narrow Band Imaging in Head and Neck Cancers

Authors: Xiao-Guang Ni, Gui-Qi Wang

Published in: Current Oncology Reports | Issue 2/2016

Login to get access

Abstract

Early diagnosis of malignant tumors in the head and neck region is very difficult. Therefore, endoscopic systems with narrow band imaging (NBI), which enhances image contrast, have an important clinical value in detecting superficial mucosal lesions. In particular, highlighting of the intraepithelial microvasculature helps determine the nature of the lesion. This new image-enhanced technology already has proven effective in the early diagnosis of head and neck squamous cell carcinoma, including laryngeal, hypopharyngeal, oropharyngeal, nasopharyngeal, and oral cancers, as well as of unknown primary cervical lymph node metastasis. NBI laryngoscopy can be applied easily in clinical practice and has become a valuable tool in diagnosing head and neck cancers early, providing the option of minimally invasive treatment such as endoscopic or partial surgical resection.
Literature
1.
Tan NC, Herd MK, Brennan PA, Puxeddu R. The role of narrow band imaging in early detection of head and neck cancer. Br J Oral Maxillofac Surg. 2012;50(2):132–6.CrossRefPubMed
2.
Piazza C, Dessouky O, Peretti G, Cocco D, De Benedetto L, Nicolai P. Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature. Acta Otorhinolaryngol Ital. 2008;28(2):49–54.PubMedCentralPubMed
3.
Larghi A, Lecca PG, Costamagna G. High-resolution narrow band imaging endoscopy. Gut. 2008;57(7):976–86.CrossRefPubMed
4.•
Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9(3):568–77. This study indicated that the NBI filter set (415 ± 30 nm, 445 ± 30 nm, 500 ± 30 nm) was selected to achieve the preferred appearance of the vascular patterns for clinical tests.CrossRefPubMed
5.
6.••
Inoue H, Kaga M, Ikeda H, Sato C, Sato H, Minami H, et al. Magnification endoscopy in esophageal squamous cell carcinoma: a review of the intrapapillary capillary loop classification. Ann Gastroenterol. 2015;28(1):41–8. This review article summarizes the first endoscopic description of IPCLs and traces it to the eventual development of the IPCL classification, focusing particularly on early-stage squamous cell carcinoma of the esophagus.PubMedCentralPubMed
7.
Kumagai Y, Inoue H, Nagai K, Kawano T, Iwai T. Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy. 2002;34(5):369–75.CrossRefPubMed
8.••
Sato H, Inoue H, Ikeda H, Sato C, Onimaru M, Hayee B, et al. Utility of intrapapillary capillary loops seen on magnifying narrow-band imaging in estimating invasive depth of esophageal squamous cell carcinoma. Endoscopy. 2015;47(2):122–8. This study used IPCLs to estimate histopathologic atypia and invasion depth of squamous cell carcinoma.CrossRefPubMed
9.
Sano Y, Kobayashi M, Hamamoto Y. New diagnostic method based on color imaging using narrowband imaging (NBI) system for gastrointestinal tract. Gastrointest Endosc. 2001;53(5):AB125.
10.
Boeriu A, Boeriu C, Drasovean S, Pascarenco O, Mocan S, Stoian M, et al. Narrow-band imaging with magnifying endoscopy for the evaluation of gastrointestinal lesions. World J Gastrointest Endosc. 2015;7(2):110–20.PubMedCentralCrossRefPubMed
11.
Herth FJ, Eberhardt R, Anantham D, Gompelmann D, Zakaria MW, Ernst A. Narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection. J Thorac Oncol. 2009;4(9):1060–5.CrossRefPubMed
12.
Kikuchi O, Ezoe Y, Morita S, Horimatsu T, Muto M. Narrow-band imaging for the head and neck region and the upper gastrointestinal tract. Jpn J Clin Oncol. 2013;43(5):458–65.CrossRefPubMed
13.
Casey RG, Catto JW, Cheng L, Cookson MS, Herr H, Shariat S, et al. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol. 2015;67(5):876–88.CrossRefPubMed
14.
Watanabe A, Taniguchi M, Tsujie H, Hosokawa M, Fujita M, Sasaki S. The value of narrow band imaging for early detection of laryngeal cancer. Eur Arch Otorhinolaryngol. 2009;266(7):1017–23.CrossRefPubMed
15.
Piazza C, Cocco D, De Benedetto L, Del Bon F, Nicolai P, Peretti G. Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients. Eur Arch Otorhinolaryngol. 2010;267(3):409–14.CrossRefPubMed
16.••
Ni XG, He S, Xu ZG, Gao L, Lu N, Yuan Z, et al. Endoscopic diagnosis of laryngeal cancer and precancerous lesions by narrow band imaging. J Laryngol Otol. 2011;125(3):288–96. These authors were the first to classify the IPCL with regard to the laryngeal mucosal microvasculature. They also evaluated the value of NBI in the early diagnosis of laryngeal precancerous and cancerous lesions.CrossRefPubMed
17.
Bertino G, Cacciola S, Fernandes Jr WB, Fernandes CM, Occhini A, Tinelli C, et al. Effectiveness of narrow band imaging in the detection of premalignant and malignant lesions of the larynx: validation of a new endoscopic clinical classification. Head Neck. 2015;37(2):215–22.CrossRefPubMed
18.
Kraft M, Fostiropoulos K, Gürtler N, Arnoux A, Davaris N, Arens C. Value of narrow band imaging in the early diagnosis of laryngeal cancer. Head Neck. 2014. doi:10.​1002/​hed.​23838.PubMed
19.
Zabrodsky M, Lukes P, Lukesova E, Boucek J, Plzak J. The role of narrow band imaging in the detection of recurrent laryngeal and hypopharyngeal cancer after curative radiotherapy. Biomed Res Int. 2014;2014:175398.PubMedCentralCrossRefPubMed
20.••
Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010;28(9):1566–72. This multicenter randomized controlled trial showed that NBI can detect superficial cancer more frequently than WL in both the head and neck region and the esophagus.PubMedCentralCrossRefPubMed
21.
Yoshimura N, Goda K, Tajiri H, Yoshida Y, Kato T, Seino Y, et al. Diagnostic utility of narrow-band imaging endoscopy for pharyngeal superficial carcinoma. World J Gastroenterol. 2011;17(45):4999–5006.PubMedCentralCrossRefPubMed
22.
Tateya I, Muto M, Morita S, Miyamoto S, Hayashi T, Funakoshi M, Aoyama I, Higuchi H, Hirano S, Kitamura M, Ishikawa S, Kishimoto Y, Morita M, Ito J. Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer. Surg Endosc. 2015.
23.
Muto M, Satake H, Yano T, Minashi K, Hayashi R, Fujii S, et al. Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc. 2011;74(3):477–84.CrossRefPubMed
24.
Satake H, Yano T, Muto M, Minashi K, Yoda Y, Kojima T, et al. Clinical outcome after endoscopic resection for superficial pharyngeal squamous cell carcinoma invading the subepithelial layer. Endoscopy. 2015;47(1):11–8.PubMed
25.
Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ. Emerging treatment options for nasopharyngeal carcinoma. Drug Des Devel Ther. 2013;7:37–52.PubMedCentralPubMed
26.
Wang WH, Lin YC, Lee KF, Weng HH. Nasopharyngeal carcinoma detected by narrow-band imaging endoscopy. Oral Oncol. 2011;47(8):736–41.CrossRefPubMed
27.•
Wen YH, Zhu XL, Lei WB, Zeng YH, Sun YQ, Wen WP. Narrow-band imaging: a novel screening tool for early nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2012;138(2):183–8. This study showed that NBI endoscopy is a promising tool to differentiate nonmalignant from malignant nasopharyngeal lesions on the basis of the morphologic findings of mucosal capillary vessels in vivo.CrossRefPubMed
28.
Takano JH, Yakushiji T, Kamiyama I, Nomura T, Katakura A, Takano N, et al. Detecting early oral cancer: narrowband imaging system observation of the oral mucosa microvasculature. Int J Oral Maxillofac Surg. 2010;39(3):208–13.CrossRefPubMed
29.
Shibahara T, Yamamoto N, Yakushiji T, Nomura T, Sekine R, Muramatsu K, et al. Narrow-band imaging system with magnifying endoscopy for early oral cancer. Bull Tokyo Dent Coll. 2014;55(2):87–94.CrossRefPubMed
30.•
Yang SW, Lee YS, Chang LC, Hwang CC, Chen TA. Diagnostic significance of narrow-band imaging for detecting high-grade dysplasia, carcinoma in situ, and carcinoma in oral leukoplakia. Laryngoscope. 2012;122(12):2754–61. This study showed that NBI pictures of a twisted, elongated IPCL and of IPCL pattern destruction indicate high-grade dysplasia or carcinomatous lesions in oral leukoplakia.CrossRefPubMed
31.
Yang SW, Lee YS, Chang LC, Hwang CC, Luo CM, Chen TA. Clinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology. BMC Cancer. 2015;15(1):406.PubMedCentralCrossRefPubMed
32.
Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev. 2004;30(2):153–64.CrossRefPubMed
33.
Ni XG, Cheng RR, Lai SQ, Zhang L, He S, Zhang YM, et al. Value of narrow band imaging endoscopy in the detection of unknown primary site with cervical lymph node metastasis of squamous cell carcinoma. Zhonghua Zhong Liu Za Zhi. 2013;35(9):698–702. Chinese.PubMed
34.
Hayashi T, Muto M, Hayashi R, Minashi K, Yano T, Kishimoto S, et al. Usefulness of narrow-band imaging for detecting the primary tumor site in patients with primary unknown cervical lymph node metastasis. Jpn J Clin Oncol. 2010;40(6):537–41.PubMedCentralCrossRefPubMed
35.
Shinozaki T, Hayashi R, Ebihara M, Miyazaki M, Daiko H, Saikawa M, et al. Narrow band imaging endoscopy for unknown primary tumor sites of the neck. Head Neck. 2012;34(6):826–9.CrossRefPubMed
36.
Ryu IS, Choi SH, Kim do H, Han MW, Roh JL, Kim SY, et al. Detection of the primary lesion in patients with cervical metastases from unknown primary tumors with narrow band imaging endoscopy: preliminary report. Head Neck. 2013;35(1):10–4.CrossRefPubMed
37.
Singh R, Lee SY, Vijay N, Sharma P, Uedo N. Update on narrow band imaging in disorders of the upper gastrointestinal tract. Dig Endosc. 2014;26(2):144–53.CrossRefPubMed
38.
Piazza C, Del Bon F, Peretti G, Nicolai P. Narrow band imaging in endoscopic evaluation of the larynx. Curr Opin Otolaryngol Head Neck Surg. 2012;20(6):472–6.CrossRefPubMed
Metadata
Title
The Role of Narrow Band Imaging in Head and Neck Cancers
Authors
Xiao-Guang Ni
Gui-Qi Wang
Publication date
01-02-2016
Publisher
Springer US
Published in
Current Oncology Reports / Issue 2/2016
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-015-0498-1

Other articles of this Issue 2/2016

Current Oncology Reports 2/2016 Go to the issue

Integrative Care (C Lammersfeld, Section Editor)

Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis

Palliative Medicine (A Jatoi, Section Editor)

Communication About Sexuality in Advanced Illness Aligns With a Palliative Care Approach to Patient-Centered Care

Gastrointestinal Cancers (J Meyer, Section Editor)

Advances in the Management of Gastric and Gastroesophageal Cancers

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Breast Cancer (B Overmoyer, Section Editor)

Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer Survivors

Gastrointestinal Cancers (J Meyer, Section Editor)

Advances in Local and Systemic Therapies for Hepatocellular Cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits